Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center (J.H.Y., K.H.C., T.K.P., J.M.L., Y.B.S., J.-Y.H., S.-H.C., H.-C.G.), Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea (Y.-G.K., C.-M.A.).
Circ Heart Fail. 2021 Jun;14(6):e008141. doi: 10.1161/CIRCHEARTFAILURE.120.008141. Epub 2021 Jun 15.
In the current era of mechanical circulatory support, limited data are available on prognosis of cardiogenic shock (CS) caused by various diseases. We investigated the characteristics and predictors of in-hospital mortality in Korean patients with CS.
The RESCUE study (Retrospective and Prospective Observational Study to Investigate Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With CS) is a multicenter, retrospective, and prospective registry of patients that presented with CS. Between January 2014 and December 2018, 1247 patients with CS were enrolled from 12 major centers in Korea. The primary outcome was in-hospital mortality.
In-hospital mortality rate was 33.6%. The main causes of shock were ischemic heart disease (80.7%), dilated cardiomyopathy (6.1%), myocarditis (3.2%), and nonischemic ventricular arrhythmia (2.5%). Vasopressors were used in 1081 patients (86.7%). The most frequently used vasopressor was dopamine (63.4%) followed by norepinephrine (57.3%). An intraaortic balloon pump was used in 314 patients (25.2%) and extracorporeal membrane oxygenator in 496 patients (39.8%). In multivariable analysis, age ≥70years (odds ratio [OR], 2.73 [95% CI, 1.89-3.94], <0.001), body mass index <25 kg/m (OR, 1.52 [95% CI, 1.08-2.16], =0.017), cardiac arrest at presentation (OR, 2.16 [95% CI, 1.44-3.23], <0.001), vasoactive-inotrope score >80 (OR, 3.55 [95% CI, 2.54-4.95], <0.001), requiring continuous renal replacement therapy (OR, 4.14 [95% CI, 2.88-5.95], <0.001), mechanical ventilator (OR, 3.17 [95% CI, 2.16-4.63], <0.001), intraaortic balloon pump (OR, 1.55 [95% CI, 1.07-2.24], =0.020), and extracorporeal membrane oxygenator (OR, 1.85 [95% CI, 1.25-2.76], =0.002) were independent predictors for in-hospital mortality.
The in-hospital mortality of patients with CS remains high despite the high utilization of mechanical circulatory support. Age, low body mass index, cardiac arrest at presentation, amount of vasopressor, and advanced organ failure requiring various support devices were poor prognostic factors for in-hospital mortality. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT02985008.
在当前机械循环支持的时代,关于各种疾病引起的心源性休克(CS)的预后数据有限。我们研究了韩国 CS 患者住院死亡率的特征和预测因素。
RESCUE 研究(回顾性和前瞻性观察性研究,以调查左心室辅助装置对韩国 CS 患者的临床结果和疗效)是一项多中心、回顾性和前瞻性的 CS 患者登记研究。2014 年 1 月至 2018 年 12 月,从韩国 12 个主要中心共招募了 1247 名 CS 患者。主要结局是住院死亡率。
住院死亡率为 33.6%。休克的主要原因是缺血性心脏病(80.7%)、扩张型心肌病(6.1%)、心肌炎(3.2%)和非缺血性室性心律失常(2.5%)。1081 名患者使用了血管加压药(86.7%)。最常使用的血管加压药是多巴胺(63.4%),其次是去甲肾上腺素(57.3%)。314 名患者使用了主动脉内球囊泵(25.2%),496 名患者使用了体外膜肺氧合器(39.8%)。多变量分析显示,年龄≥70 岁(比值比[OR],2.73[95%置信区间,1.89-3.94],<0.001)、体质指数<25 kg/m(OR,1.52[95%置信区间,1.08-2.16],=0.017)、出现心脏骤停(OR,2.16[95%置信区间,1.44-3.23],<0.001)、血管活性-正性肌力评分>80(OR,3.55[95%置信区间,2.54-4.95],<0.001)、需要持续肾脏替代治疗(OR,4.14[95%置信区间,2.88-5.95],<0.001)、机械通气(OR,3.17[95%置信区间,2.16-4.63],<0.001)、主动脉内球囊泵(OR,1.55[95%置信区间,1.07-2.24],=0.020)和体外膜肺氧合器(OR,1.85[95%置信区间,1.25-2.76],=0.002)是住院死亡率的独立预测因素。
尽管机械循环支持的应用率较高,但 CS 患者的住院死亡率仍然很高。年龄、低体质指数、出现心脏骤停、血管加压药用量以及需要各种支持设备的严重器官衰竭是住院死亡率的不良预后因素。注册:网址:https://www.clinicaltrials.gov;唯一标识符:NCT02985008。